COVID-19 UPDATE

BDSI remains committed to the chronic pain community during the COVID-19 pandemic. For more
information on access to our products, please call our customer service line at 1-800-469-0261.

SEC Filing Details

SEC Filing Details

Document Details

Form
10-K
Filing Date
Mar 11, 2021
Document Date
Dec 31, 2020
Form Description
Annual report which provides a comprehensive overview of the company for the past year
Filing Group
Annual Filings
Company
BioDelivery Sciences International, Inc.
Issuer
BIODELIVERY SCIENCES INTERNATIONAL INC

Investor Presentation

More information is coming soon.


Recent BDSI News

BioDelivery Sciences Reports Strong Q4 and Record Full-Year 2020 Results March 10, 2021

Total Company Net Revenue Increased 40% versus Prior Year to Reach an All-Time High of $156.5 Million Record Level Profitability with Net Income of $25.7 Million , Full-Year EBITDA Margin of 26% and Operating Cash Generation of $25 Million Conference Call and Webcast Scheduled for 8:30 AM EST Today ...

Read more
BioDelivery Sciences to Report Fourth Quarter and Full Year 2020 Financial Results on March 10, 2021 February 17, 2021

RALEIGH, N.C. , Feb. 17, 2021 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI), a rapidly growing specialty pharmaceutical company dedicated to patients living with serious and complex chronic conditions, today announced that it will report its fourth quarter and full ...

Read more
BioDelivery Sciences CFO Terry Coelho Promoted to Executive Vice President February 11, 2021

Brings Track Record of Success to Expanded Role RALEIGH, N.C. , Feb. 11, 2021 (GLOBE NEWSWIRE) -- BioDelivery Sciences International , Inc. (NASDAQ: BDSI), a rapidly growing specialty pharmaceutical company dedicated to patients living with chronic conditions, promoted its Chief Financial Officer, ...

Read more

Upcoming Events

More events are coming soon.

Stay Connected

Stay up to date on the latest news

Get started now
March 24, 2021 /
Data provided by West LLC. Minimum 15 minutes delayed.